Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Messina

Showing results (21-30 of 106) with videos related to

Pageof 11
Sort By:
Anti-Cancer Drugs|May 17, 2016
Immunotherapy for genitourinary cancer: state of the art and new perspectivesCarlo Cattrini, Chiara Dellepiane, Alessia Cavo, et al.
Breast Cancer Research and Treatment|July 29, 2018
CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trialsCarlo Messina, Carlo Cattrini, Giulia Buzzatti, et al.
Anti-Cancer Drugs|July 12, 2016
Genitourinary tumours in the targeted therapies era: new advances in clinical practice and future perspectivesCarlo Messina, Giulia Buzzatti, Chiara Dellepiane, et al.
Journal of Clinical Medicine|January 10, 2026
The Rise of Total-Body PET/CT: Advancing Molecular Imaging Toward Early Cancer Detection and Potential Future Application in Prevention HealthcarePierpaolo Alongi, Simone Morea, Roberto Cannella, et al.
Critical Reviews in Oncology/Hematology|November 11, 2019
NUT midline carcinoma: Current concepts and future perspectives of a novel tumour entityMassimiliano Salati, Cinzia Baldessari, Luca Reggiani Bonetti, et al.
Clinical Genitourinary Cancer|May 4, 2015
A Case of Advanced Mucinous Adenocarcinoma of Bladder in an Adult Patient Treated With Capecitabine-Based Chemotherapy and Review of LiteratureCarlo Messina, Chiara Dellepiane, Cinzia Caroti, et al.
Therapeutic Advances in Urology|July 22, 2021
Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?Giandomenico Roviello, Sebastiano Buti, Carlo Cattrini, et al.
Journal of Biomedical Materials Research|March 29, 2002
Concentration- and composition-dependent effects of metal ions on human MG-63 osteoblastsNadim James Hallab, Csaba Vermes, Carlo Messina, et al.
Clinical Genitourinary Cancer|December 3, 2015
A Case of Plasmacytoid Variant of Bladder Cancer With a Single Penile Metastasis and a Complete Response to Carboplatin-Based Chemotherapy and Review of the LiteratureCarlo Messina, Elisa Zanardi, Chiara Dellepiane, et al.
Clinical Genitourinary Cancer|June 5, 2019
Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based StudyCarlo Cattrini, Luigi Cerbone, Alessandra Rubagotti, et al.
Pageof 11

Showing results (21-30 of 106) with videos related to

Sort By:
Pageof 11
Anti-Cancer Drugs|May 17, 2016
Immunotherapy for genitourinary cancer: state of the art and new perspectivesCarlo Cattrini, Chiara Dellepiane, Alessia Cavo, et al.
Breast Cancer Research and Treatment|July 29, 2018
CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trialsCarlo Messina, Carlo Cattrini, Giulia Buzzatti, et al.
Anti-Cancer Drugs|July 12, 2016
Genitourinary tumours in the targeted therapies era: new advances in clinical practice and future perspectivesCarlo Messina, Giulia Buzzatti, Chiara Dellepiane, et al.
Journal of Clinical Medicine|January 10, 2026
The Rise of Total-Body PET/CT: Advancing Molecular Imaging Toward Early Cancer Detection and Potential Future Application in Prevention HealthcarePierpaolo Alongi, Simone Morea, Roberto Cannella, et al.
Critical Reviews in Oncology/Hematology|November 11, 2019
NUT midline carcinoma: Current concepts and future perspectives of a novel tumour entityMassimiliano Salati, Cinzia Baldessari, Luca Reggiani Bonetti, et al.
Clinical Genitourinary Cancer|May 4, 2015
A Case of Advanced Mucinous Adenocarcinoma of Bladder in an Adult Patient Treated With Capecitabine-Based Chemotherapy and Review of LiteratureCarlo Messina, Chiara Dellepiane, Cinzia Caroti, et al.
Therapeutic Advances in Urology|July 22, 2021
Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?Giandomenico Roviello, Sebastiano Buti, Carlo Cattrini, et al.
Journal of Biomedical Materials Research|March 29, 2002
Concentration- and composition-dependent effects of metal ions on human MG-63 osteoblastsNadim James Hallab, Csaba Vermes, Carlo Messina, et al.
Clinical Genitourinary Cancer|December 3, 2015
A Case of Plasmacytoid Variant of Bladder Cancer With a Single Penile Metastasis and a Complete Response to Carboplatin-Based Chemotherapy and Review of the LiteratureCarlo Messina, Elisa Zanardi, Chiara Dellepiane, et al.
Clinical Genitourinary Cancer|June 5, 2019
Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based StudyCarlo Cattrini, Luigi Cerbone, Alessandra Rubagotti, et al.
Pageof 11